Natera To Host Investor Conference Call to Discuss Strategic Roadmap in Organ Transplantation and Oncology
Natera To Host Investor Conference Call to Discuss Strategic Roadmap in Organ Transplantation and Oncology Commercializing Core Cell-free DNA Technology Beyond Reproductive Health |
[21-June-2018] |
SAN CARLOS, Calif., June 21, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in genetic testing and cell-free DNA analysis, will share data and roadmap for its emerging businesses in renal transplantation and oncology, during an investor call on June 27, 2018.
A webcast replay will be available at investor.natera.com. About Natera Contacts
View original content with multimedia:http://www.prnewswire.com/news-releases/natera-to-host-investor-conference-call-to-discuss-strategic-roadmap-in-organ-transplantation-and-oncology-300670435.html SOURCE Natera, Inc. | ||||||||||||||||
Company Codes: NASDAQ-NMS:NTRA |
© 2018 PR Newswire. All Rights Reserved.
#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}